126 related articles for article (PubMed ID: 26406959)
1. Retrospective analysis of TGF-β 1 expression in patients with thyroidectomy.
Li J; Wei F
Cancer Biomark; 2015; 15(5):693-8. PubMed ID: 26406959
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of transforming growth factor-beta in benign vs. papillary thyroid cancer nodules; a potential diagnostic tool?
Brace MD; Wang J; Petten M; Bullock MJ; Makki F; Trites J; Taylor SM; Hart RD
J Otolaryngol Head Neck Surg; 2014 Jul; 43(1):22. PubMed ID: 25927212
[TBL] [Abstract][Full Text] [Related]
3. The reliability of fine-needle aspiration biopsy in terms of malignancy in patients with Hashimoto thyroiditis.
Kapan M; Onder A; Girgin S; Ulger BV; Firat U; Uslukaya O; Oguz A
Int Surg; 2015 Feb; 100(2):249-53. PubMed ID: 25692426
[TBL] [Abstract][Full Text] [Related]
4. Notch and TGF-β/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma.
Zhang J; Wang Y; Li D; Jing S
Tumour Biol; 2014 Jan; 35(1):379-85. PubMed ID: 23918305
[TBL] [Abstract][Full Text] [Related]
5. Transforming Growth Factor β1 Could Influence Thyroid Nodule Elasticity and Also Improve Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Li Y; Wang Y; Wu Q; Hu B
Ultrasound Med Biol; 2015 Nov; 41(11):2866-72. PubMed ID: 26306431
[TBL] [Abstract][Full Text] [Related]
6. The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the performance of the Afirma gene expression classifier.
Hang JF; Westra WH; Cooper DS; Ali SZ
Cancer Cytopathol; 2017 Sep; 125(9):683-691. PubMed ID: 28544601
[TBL] [Abstract][Full Text] [Related]
7. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
Jara SM; Bhatnagar R; Guan H; Gocke CD; Ali SZ; Tufano RP
Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
[TBL] [Abstract][Full Text] [Related]
8. False-positive cytopathology results for papillary thyroid carcinoma: A trap for thyroid surgeons.
Yi KI; Ahn S; Park DY; Lee JC; Lee BJ; Wang SG; Cha W
Clin Otolaryngol; 2017 Dec; 42(6):1153-1160. PubMed ID: 28130940
[TBL] [Abstract][Full Text] [Related]
9. Generation of a Potential Prognostic Matrix for Papillary Thyroid Cancer that Assesses Age, Tumor Size, Transforming Growth Factor-β, and BRAFV600E Mutation.
Wang P; Lun Y; Fu Y; Wang F; Zhao S; Wang Y; Hou X
Oncol Res Treat; 2017; 40(10):586-592. PubMed ID: 28892804
[TBL] [Abstract][Full Text] [Related]
10. BRAF V600E detection in cytological thyroid samples: A key component of the decision tree for surgical treatment of papillary thyroid carcinoma.
Collet JF; Lacave R; Hugonin S; Poulot V; Tassart M; Fajac A
Head Neck; 2016 Jul; 38(7):1017-21. PubMed ID: 26854757
[TBL] [Abstract][Full Text] [Related]
11. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
Paek SH; Kim BS; Kang KH; Kim HS
World J Surg Oncol; 2017 Nov; 15(1):202. PubMed ID: 29132392
[TBL] [Abstract][Full Text] [Related]
12. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
13. Nuclear morphometric findings in undetermined cytology: A possible clue for prediction of BRAF mutation in papillary thyroid carcinomas.
Mungan S; Ersoz S; Saygin I; Sagnak Z; Cobanoglu U
Endocr Res; 2017 May; 42(2):138-144. PubMed ID: 27911099
[TBL] [Abstract][Full Text] [Related]
14. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
Zimmermann AK; Camenisch U; Rechsteiner MP; Bode-Lesniewska B; Rössle M
Cancer Cytopathol; 2014 Jan; 122(1):48-58. PubMed ID: 24039206
[TBL] [Abstract][Full Text] [Related]
15. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
Zhao L; Dias-Santagata D; Sadow PM; Faquin WC
Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
18. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
19. Hyalinizing trabecular tumor masquerading as papillary thyroid carcinoma on fine-needle aspiration.
Howard BE; Gnagi SH; Ocal IT; Hinni ML
ORL J Otorhinolaryngol Relat Spec; 2013; 75(6):309-13. PubMed ID: 24107636
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas.
Proietti A; Borrelli N; Giannini R; Romani R; Di Coscio G; Quilici F; Rago T; Miccoli P; Vitti P; Basolo F
Cancer Cytopathol; 2014 Oct; 122(10):751-9. PubMed ID: 24913568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
